NCT Number: NCT02525185
Contractile Reserve in Dyssynchrony: A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy
Cardiac resynchronisation therapy (CRT) has been documented to be a powerful treatment in patients with severe congestive heart failure. However, 30-40% of patients receiving a CRT are non-responders. In this study the investigators will use a previously validated method to estimate myocardial segment work non-invasively by speckle-tracking echocardiography and blood pressure. Furthermore, cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE) will be performed in feasible subjects. The main purpose of the study is to determine if myocardial work by echocardiography in combination with viability assessment by LGE-CMR can predict response to CRT.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Universitaire Ziekenhuizen Leuven, Leuven, Belgium
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subject is indicated for CRT device according to European Society of Cardiology (ESC) guidelines from 2013.
- Subject is willing to sign informed consent form and is 18 years or older.
Exclusion criteria
- Right bundle branch block.
- Recent myocardial infarction, within 40 days prior to enrollment.
- Subject underwent coronary artery bypass graft (CABG) or valve surgery, within 90 days.
- Post heart transplantation, or is actively listed on the transplantation list, or has reasonable probability (per investigator's discretion) of undergoing transplantation in the next year
- Implanted with a LV assist device (LVAD), or has reasonable probability (per investigator's discretion) of receiving a LVAD in the next year
- Severe aortic stenosis (with a valve area of <1.0 cm2 or significant valve disease expected to be operated on within study period).
- Complex and uncorrected congenital heart disease.
- Breastfeeding women or women of child bearing potential.
- Enrolled in one or more concurrent studies that would confound the results of this study.
- Impossible to obtain LV volumes by echocardiography
Treatment and study plan
Primary outcomes
-
Reverse remodelling at 6 months follow-up
Time frame: 6 months
Measured by left ventricular end-systolic volume reduction of at least 15% assessed by echocardiography
Secondary outcomes
-
Reverse remodelling at 12 months follow-up
Time frame: 12 months
Measured by left ventricular end-systolic volume reduction of at least 15% assessed by echocardiography
-
Quality of Life Changes
Time frame: 6 months
Changes in quality of life measured by the Minnesota Living With Heart Failure Questionnaire
-
New York Heart Association (NYHA) Class Changes
Time frame: 6 months
-
Heart failure hospitalizations
Time frame: 12 months
-
Death of any cause
Time frame: 5 years
-
Heart transplantation
Time frame: 5 years
-
Left atrial contractile synchrony
Time frame: 2 years
Sponsors and collaborators
Lead sponsor
Oslo University Hospital
Other
Collaborators
- Karolinska University Hospital
- Onze Lieve Vrouwziekenhuis Aalst
- Rennes University Hospital
- Universitaire Ziekenhuizen KU Leuven
Registry information
Official study title
Contractile Reserve in Dyssynchrony (CRID): A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy
Acronym: CRID-CRT
Important dates
- Study start
- 2015
- Primary completion
- 2018
- Study completion
- 2023
- First posted
- Aug 17, 2015
- Registry last updated
- Nov 1, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
NCT01648634
Cardiomyopathies, Cardiomyopathy
Paris, France
View Trial DetailsMechanisms of Improvement With Beta-Blocker Treatment in Heart Failure
NCT01261065
Cardiomyopathies, Cardiomyopathy
Houston, Texas, United States
View Trial DetailsAdaptive CRT Effect on Electrical Dyssynchrony
NCT02543281
Arrhythmias, Cardiac, Bundle-Branch Block
Portland, Oregon, United States
View Trial DetailsNebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population
NCT02077010
Cardiomyopathies, Cardiomyopathy
Kansas City, Kansas, United States
View Trial Details